MedTrace Logo

CYFIP1 and PKM2 Synergistically Regulate ROS and Glycolysis in Colorectal Cancer Through the AKT/mTOR/HIF-1α Cascad

NCT07197151 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2025-09-29

No results posted yet for this study

Summary

Collect some tumor tissue specimens from patients who have undergone colorectal cancer surgery and conduct experiments such as immunohistochemistry to observe the expression of related genes in colorectal cancer.

Conditions

  • Colorectal Cancer (CRC)
  • Specimens Are to be Collected From Subjects Who Are Having or Have Had a Fluid or Tissue Removed, a Biopsy or a Blood or Bone Marrow Draw

Interventions

OTHER

Perform surgery on patients with colorectal cancer and collect cancer and adjacent tissue specimens

Perform surgery on patients with colorectal cancer and collect cancer and adjacent tissue specimens

Sponsors & Collaborators

  • hui hou

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2025-09-01
Completion
2025-09-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07197151 on ClinicalTrials.gov